Inspection Record

Medicago Inc. — Health Canada Inspection Findings

Health CanadaInspected 2021-07-07 4 findingsLaboratory and QC controlsStability and storageOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

The quality control department was not involved in all decisions for the quality of the product.

2Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

3Other quality system

The recorded information or details were inadequate.

4Stability and storage

The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-07-07. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Medicago Inc. company profile — full history Health Canada documents, 2021 Go to Findings search